Douglas J. Fansher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Douglas J. Fansher has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Joelle N. Pelletier
Department of Chemistry, Université de Montréal, Montréal, QC H2V 0B3, Canada
3 shared publications - David R. J. Palmer
University of Saskatchewan 110 Science Place
2 shared publications Jonathan N. Besna
Department of Biochemistry, and Molecular Medicine, Université de Montréal, 2900 Boulevard Édouard-Montpetit, Montréal, Québec H3T 1J4, Canada
2 shared publicationsAli Fendri
Chemistry Department, Université de Montréal, Montreal, QC, Canada H2V 0B3
1 shared publicationClaudèle Lemay-St-Denis
Department of Biochemistry, and Molecular Medicine, Université de Montréal, 2900 Boulevard Édouard-Montpetit, Montréal, Québec H3T 1J4, Canada
1 shared publicationDonya Valikhani
PROTEO, the Québec Network for Protein Function, Engineering and Applications
1 shared publication
Latest Publications
- 19 December 2025
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (1) , 404-417
Indigo Formation as a Predictor of Non-Native Aromatic Hydroxylation in Cytochrome P450 BM3
Screening cytochrome P450 BM3 enzyme for specific non-native reactivity is challenging. This enzyme is natively promiscuous in hydroxylation and epoxidation reactions and directed evolution has broadened its scope of reactivity, making it valuable in synthetic schemes. To accelerate discovery of further targets of reactivity, this study investigates indigo formation as a cost-effective predictive marker for hydroxylation of non-native aromatic compounds. Following site-saturation mutagenesis at 42 active-site positions, we identified 142 previously unreported indigo-producing variants that were point-substituted at one of 23 positions, substantially increasing the database of indigo-producing variants. From this pool, 81 well-expressed indigo-positive and 46 indigo-negative variants were screened for hydroxylation of 17 aromatic compounds that are not native substrates of P450 BM3 using the colorimetric 4-aminoantipyrine assay; 10 of the compounds were found to be good substrates for hydroxylation by many variants. Although MD simulations identified no property clearly distinguishing indigo-positive from indigo-negative variants, we found indigo-positive variants to exhibit significantly higher activity and substrate promiscuity, on average. For instance, relative to wild-type P450 BM3, 93% of indigo-positive variants displayed ≥ 7-fold increased hydroxylation of 1-Br-naphthalene compared to only 9% of indigo-negative variants. Increased substrate promiscuity is illustrated by Spearman correlations of reactivity, reaching ≥ 0.7 for 12 substrate pairs. Furthermore, the 10 variants ranked most promiscuous and most active for aromatic hydroxylation are all indigo-positive. We thus found that screening for indigo formation by visualizing E. coli colonies allowed reliable identification of all the top point-substituted variants, with a high hit-rate of increased substrate promiscuity and activity increased up to 167-fold relative to the native enzyme. This efficient screen will serve as a powerful primary tool to accelerate the expansion of the functional repertoire of P450 BM3 variants. Our findings are presented in machine-readable format to aid ulterior machine learning, providing a foundation for computational advances to predict further substrate-variant combinations.
- 19 December 2025
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (1) , 404-417
Indigo Formation as a Predictor of Non-Native Aromatic Hydroxylation in Cytochrome P450 BM3
Screening cytochrome P450 BM3 enzyme for specific non-native reactivity is challenging. This enzyme is natively promiscuous in hydroxylation and epoxidation reactions and directed evolution has broadened its scope of reactivity, making it valuable in synthetic schemes. To accelerate discovery of further targets of reactivity, this study investigates indigo formation as a cost-effective predictive marker for hydroxylation of non-native aromatic compounds. Following site-saturation mutagenesis at 42 active-site positions, we identified 142 previously unreported indigo-producing variants that were point-substituted at one of 23 positions, substantially increasing the database of indigo-producing variants. From this pool, 81 well-expressed indigo-positive and 46 indigo-negative variants were screened for hydroxylation of 17 aromatic compounds that are not native substrates of P450 BM3 using the colorimetric 4-aminoantipyrine assay; 10 of the compounds were found to be good substrates for hydroxylation by many variants. Although MD simulations identified no property clearly distinguishing indigo-positive from indigo-negative variants, we found indigo-positive variants to exhibit significantly higher activity and substrate promiscuity, on average. For instance, relative to wild-type P450 BM3, 93% of indigo-positive variants displayed ≥ 7-fold increased hydroxylation of 1-Br-naphthalene compared to only 9% of indigo-negative variants. Increased substrate promiscuity is illustrated by Spearman correlations of reactivity, reaching ≥ 0.7 for 12 substrate pairs. Furthermore, the 10 variants ranked most promiscuous and most active for aromatic hydroxylation are all indigo-positive. We thus found that screening for indigo formation by visualizing E. coli colonies allowed reliable identification of all the top point-substituted variants, with a high hit-rate of increased substrate promiscuity and activity increased up to 167-fold relative to the native enzyme. This efficient screen will serve as a powerful primary tool to accelerate the expansion of the functional repertoire of P450 BM3 variants. Our findings are presented in machine-readable format to aid ulterior machine learning, providing a foundation for computational advances to predict further substrate-variant combinations.
- 12 July 2024
- Published by Royal Society of Chemistry (RSC) in Faraday Discussions
- Vol. 252, 29-51
Indigo production identifies hotspots in cytochrome P450 BM3 for diversifying aromatic hydroxylation
Evolution of P450 BM3 is a topic of extensive research, but screening the various substrate/reaction combinations remains a time-consuming process. Indigo production has the potential to serve as a simple high-throughput method for reaction screening, as bacterial colonies expressing indigo (+) variants can be visually identified via their blue phenotype. Indigo (+) single variants, indigo (−) single variants and a combinatorial library, containing mutations that enable the blue phenotype, were screened for their ability to hydroxylate a panel of 12 aromatic compounds using the 4-aminoantipyrine colorimetric assay. Recombination of indigo (+) single variants to create a multiple-variant library is a particularly useful strategy, as all top performing P450 BM3 variants with high hydroxylation activity were either indigo (+) single variants or contained multiple substitutions. Furthermore, active variants, as determined using the 4-AAP assay, were further characterized and several variants were identified that gave more than 90% conversion with 1,3-dichlorobenzene and predominantly formed 2,6-dichlorophenol; other variants showed significant substrate selectivity. This supports the hypothesis that substitution at positions that enable the indigo (+) phenotype, or hotspot residues, is a general mechanism for increasing aromatic hydroxylation activity. Overall, this research demonstrates that indigo (+) single variants, identified via colorimetric colony-based screening, may be recombined to generate a multiply-substituted variant library containing many variants with high aromatic hydroxylation activity. The combination of colony-based screening and other screening assays greatly accelerates enzyme engineering, as readily-identified indigo (+) single variants can be recombined to create a library of active multiple variants without extensive screening of single variants.
- 12 July 2024
- Published by Royal Society of Chemistry (RSC) in Faraday Discussions
- Vol. 252, 29-51
Indigo production identifies hotspots in cytochrome P450 BM3 for diversifying aromatic hydroxylation
Evolution of P450 BM3 is a topic of extensive research, but screening the various substrate/reaction combinations remains a time-consuming process. Indigo production has the potential to serve as a simple high-throughput method for reaction screening, as bacterial colonies expressing indigo (+) variants can be visually identified via their blue phenotype. Indigo (+) single variants, indigo (−) single variants and a combinatorial library, containing mutations that enable the blue phenotype, were screened for their ability to hydroxylate a panel of 12 aromatic compounds using the 4-aminoantipyrine colorimetric assay. Recombination of indigo (+) single variants to create a multiple-variant library is a particularly useful strategy, as all top performing P450 BM3 variants with high hydroxylation activity were either indigo (+) single variants or contained multiple substitutions. Furthermore, active variants, as determined using the 4-AAP assay, were further characterized and several variants were identified that gave more than 90% conversion with 1,3-dichlorobenzene and predominantly formed 2,6-dichlorophenol; other variants showed significant substrate selectivity. This supports the hypothesis that substitution at positions that enable the indigo (+) phenotype, or hotspot residues, is a general mechanism for increasing aromatic hydroxylation activity. Overall, this research demonstrates that indigo (+) single variants, identified via colorimetric colony-based screening, may be recombined to generate a multiply-substituted variant library containing many variants with high aromatic hydroxylation activity. The combination of colony-based screening and other screening assays greatly accelerates enzyme engineering, as readily-identified indigo (+) single variants can be recombined to create a library of active multiple variants without extensive screening of single variants.
- Open Access
- 29 March 2024
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 14 (8) , 5560-5592
Choose Your Own Adventure: A Comprehensive Database of Reactions Catalyzed by Cytochrome P450 BM3 Variants
Cytochrome P450 BM3 monooxygenase is the topic of extensive research as many researchers have evolved this enzyme to generate a variety of products. However, the abundance of information on increasingly diversified variants of P450 BM3 that catalyze a broad array of chemistry is not in a format that enables easy extraction and interpretation. We present a database that categorizes variants by their catalyzed reactions and includes details about substrates to provide reaction context. This database of >1500 P450 BM3 variants is downloadable and machine-readable and includes instructions to maximize ease of gathering information. The database allows rapid identification of commonly reported substitutions, aiding researchers who are unfamiliar with the enzyme in identifying starting points for enzyme engineering. For those actively engaged in engineering P450 BM3, the database, along with this review, provides a powerful and user-friendly platform to understand, predict, and identify the attributes of P450 BM3 variants, encouraging the further engineering of this enzyme.
- 29 March 2024
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 14 (8) , 5560-5592
Open AccessChoose Your Own Adventure: A Comprehensive Database of Reactions Catalyzed by Cytochrome P450 BM3 Variants
Cytochrome P450 BM3 monooxygenase is the topic of extensive research as many researchers have evolved this enzyme to generate a variety of products. However, the abundance of information on increasingly diversified variants of P450 BM3 that catalyze a broad array of chemistry is not in a format that enables easy extraction and interpretation. We present a database that categorizes variants by their catalyzed reactions and includes details about substrates to provide reaction context. This database of >1500 P450 BM3 variants is downloadable and machine-readable and includes instructions to maximize ease of gathering information. The database allows rapid identification of commonly reported substitutions, aiding researchers who are unfamiliar with the enzyme in identifying starting points for enzyme engineering. For those actively engaged in engineering P450 BM3, the database, along with this review, provides a powerful and user-friendly platform to understand, predict, and identify the attributes of P450 BM3 variants, encouraging the further engineering of this enzyme.
- 29 December 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (6) , e202214539
A Type 1 Aldolase, NahE, Catalyzes a Stereoselective Nitro‐Michael Reaction: Synthesis of β‐Aryl‐γ‐nitrobutyric Acids
Michael addition reactions are highly useful in organic synthesis and are commonly accomplished using organocatalysts. However, the corresponding biocatalytic Michael additions are rare, typically lack synthetically useful substrate scope, and suffer from low stereoselectivity. Herein we report a biocatalytic nitro‐Michael addition, catalyzed by NahE, that proceeds with low catalyst loading at room temperature in moderate to excellent enantioselectivity and high yields. A series of β‐nitrostyrenes reacted with pyruvate in the presence of NahE to give, after oxidative decarboxylation, β‐aryl‐γ‐nitrobutyric acids in up to 99 % yield without need for chromatography, providing a simple preparative‐scale route to chiral GABA analogues. This reaction represents the first example of an aldolase displaying promiscuous Michaelase activity and opens the use of nitroalkenes in place of aldehydes as substrates for aldolases.
- 29 December 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (6) , e202214539
A Type 1 Aldolase, NahE, Catalyzes a Stereoselective Nitro‐Michael Reaction: Synthesis of β‐Aryl‐γ‐nitrobutyric Acids
Michael addition reactions are highly useful in organic synthesis and are commonly accomplished using organocatalysts. However, the corresponding biocatalytic Michael additions are rare, typically lack synthetically useful substrate scope, and suffer from low stereoselectivity. Herein we report a biocatalytic nitro‐Michael addition, catalyzed by NahE, that proceeds with low catalyst loading at room temperature in moderate to excellent enantioselectivity and high yields. A series of β‐nitrostyrenes reacted with pyruvate in the presence of NahE to give, after oxidative decarboxylation, β‐aryl‐γ‐nitrobutyric acids in up to 99 % yield without need for chromatography, providing a simple preparative‐scale route to chiral GABA analogues. This reaction represents the first example of an aldolase displaying promiscuous Michaelase activity and opens the use of nitroalkenes in place of aldehydes as substrates for aldolases.
- 29 December 2022
- Published by Wiley in Angewandte Chemie
- Vol. 135 (6)
A Type 1 Aldolase, NahE, Catalyzes a Stereoselective Nitro‐Michael Reaction: Synthesis of β‐Aryl‐γ‐nitrobutyric Acids
Michael addition reactions are highly useful in organic synthesis and are commonly accomplished using organocatalysts. However, the corresponding biocatalytic Michael additions are rare, typically lack synthetically useful substrate scope, and suffer from low stereoselectivity. Herein we report a biocatalytic nitro‐Michael addition, catalyzed by NahE, that proceeds with low catalyst loading at room temperature in moderate to excellent enantioselectivity and high yields. A series of β‐nitrostyrenes reacted with pyruvate in the presence of NahE to give, after oxidative decarboxylation, β‐aryl‐γ‐nitrobutyric acids in up to 99 % yield without need for chromatography, providing a simple preparative‐scale route to chiral GABA analogues. This reaction represents the first example of an aldolase displaying promiscuous Michaelase activity and opens the use of nitroalkenes in place of aldehydes as substrates for aldolases.
- 29 December 2022
- Published by Wiley in Angewandte Chemie
- Vol. 135 (6)
A Type 1 Aldolase, NahE, Catalyzes a Stereoselective Nitro‐Michael Reaction: Synthesis of β‐Aryl‐γ‐nitrobutyric Acids
Michael addition reactions are highly useful in organic synthesis and are commonly accomplished using organocatalysts. However, the corresponding biocatalytic Michael additions are rare, typically lack synthetically useful substrate scope, and suffer from low stereoselectivity. Herein we report a biocatalytic nitro‐Michael addition, catalyzed by NahE, that proceeds with low catalyst loading at room temperature in moderate to excellent enantioselectivity and high yields. A series of β‐nitrostyrenes reacted with pyruvate in the presence of NahE to give, after oxidative decarboxylation, β‐aryl‐γ‐nitrobutyric acids in up to 99 % yield without need for chromatography, providing a simple preparative‐scale route to chiral GABA analogues. This reaction represents the first example of an aldolase displaying promiscuous Michaelase activity and opens the use of nitroalkenes in place of aldehydes as substrates for aldolases.